4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-049841
VP, Clinical Trial Operations sold 10,400 shares at an average $21.89 ($227,630)
- VP, Clinical Trial Operations acquired 10,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-15 | Exercise or conversion : show line 1 in the form | +10,400 | $6.00 | $62,400 | 116,535 | D |
| 2023-09-15 | Sale : show line 2 in the form | −5,725 | $21.56 | $123,418 | 110,810 | D |
| 2023-09-15 | Sale : show line 3 in the form | −4,675 | $22.29 | $104,212 | 106,135 | D |
| Open-market sales · 10,400 sh · avg $21.89 · $227,630 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-09-15 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −10,400 | $6.00 | 2029-09-20 | 10,400 | 229,253 | D |
Loading xslF345X05/doc4.xml…